bluebird bio, Inc. Equity-NMS: BLUE

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$5.03
Open :$4.99
Today's high :$5.16
Today's low :$4.8
52W low :$3.56
52W high :$28.6
EPS(TTM): :-24.84
Shares O/S :9.79 M
Market cap :47.87 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
bluebird bio, Inc. $4.89 +0% - 47.87M

Frequently Asked Questions

What is the share price of bluebird bio, Inc. today?

bluebird bio, Inc. (BLUE) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About bluebird bio, Inc.

bluebird bio, Inc. is a biotechnology company. The Company is focused on researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its lentiviral vector (LVV) gene addition platform. It markets three gene therapies: ZYNTEGLO (betibeglogene autotemcel, also known as beti-cel), SKYSONA (elivaldogene autotemcel, also known as eli-cel), and LYFGENIA (lovotibeglogene autotemcel, also known as lovo-cel). ZYNTEGLO is the first gene therapy for the treatment of adult and pediatric patients with ß-thalassemia who require regular red blood cell transfusions. SKYSONA is used to slow the progression of neurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD). LYFGENIA was approved by the FDA for the treatment of patients 12 years of age or older with sickle cell disease (SCD) and a history of vaso-occlusive events (VOEs). It is focused on pursuing curative gene therapies.